Global OTC Drug And Dietary Supplement Market Forecast to Reach $462.36 Billion by 2029, Driven by 7.0% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the OTC Drug And Dietary Supplement Market Heading Into 2029?
The market size for OTC drugs and dietary supplements has experienced robust growth in recent times. The market is set to expand from $332.52 billion in 2024 to $352.4 billion in 2025, registering a compound annual growth rate (CAGR) of 6.0%. Several factors have contributed to this growth in the historical period, including a rise in fitness enthusiasts, demographic transitions and an aging population, approvals from regulatory bodies and ensuring safety standards, growth in pharmacy and retail arenas, and effective marketing and promotional strategies.
In the coming years, there’s an anticipated robust expansion in the size of the OTC drug and dietary supplement market. It’s projected to reach “$462.36 billion in 2029“, experiencing a compound annual growth rate (CAGR) of 7.0%. This projected growth over the forecast period can be credited to factors such as personal nutrition and supplement choices, nutraceutical advancements, the proliferation of functional foods, the preparedness and response to worldwide health emergencies, as well as wellness campaigns by governments. The forecast period is also expected to witness significant trends such as innovation in products, the focus on clean labels and natural constituents, the rise of cannabidiol (CBD) and hemp-based goods, sustainable and environmentally-friendly packaging, and strategic partnerships and alliances.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12096&type=smp
Which Factors Are Pushing The OTC Drug And Dietary Supplement Market Forward?
The OTC drug and dietary supplement market is anticipated to flourish due to an increase in pharma R&D spending. This investment pertains to the expenditure by a company on research, development, and improvement of its products. Higher spending could lead to more creative and productive design and formulation of OTC and dietary supplements. For example, Eurostat, a statistical office in Luxembourg under the European Union, reported in December 2023 that the R&D expenditure for the EU in 2022 amounted to €352 billion ($384.42 billion), a 6.34% increase from €331 billion ($361.48 billion) in the previous year. Hence, the growth in pharma R&D spending is propelling the OTC drug and dietary supplement market forward.
The otc drug and dietary supplement market covered in this report is segmented –
1) By Category: Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other Categories
2) By Dosage Form: Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms
3) By Application: Pharmacies, Grocery Stores, Vitamin And Health Food Stores, Online Pharmacies
Subsegments:
1) By Vitamin And Dietary Supplements: Multivitamins, Mineral Supplements, Herbal Supplements, Omega-3 Fatty Acids, Probiotics, Specialty Supplements
2) By Cough And Cold Products: Cough Suppressants, Expectorants, Decongestants, Combination Products
3) By Analgesics: Acetaminophen, NSAIDs, Topical Analgesics
4) By Gastrointestinal Products: Antacids, Laxatives, Antidiarrheals, Proton Pump Inhibitors
5) By Sleep Aids: Melatonin, Antihistamines, Herbal Sleep Aids
6) By Otic Products: Ear Wax Removal Aids, Ear Drops For Infections, Anti-itch Ear Products
7) By Wart Removers: Salicylic Acid Products, Cryotherapy Kits
8) By Mouth Care Products: Mouthwashes, Toothpastes, Oral Rinses For Freshness
9) By Ophthalmic Products: Artificial Tears, Allergy Eye Drops, Redness Relievers
10) By Other Categories: Nutraceuticals, Topical Treatments For Skin Conditions, First Aid Products
What Notable Trends Are Shaping The Direction Of The OTC Drug And Dietary Supplement Market?
The emergence of product innovation is a significant trend in the over-the-counter (OTC) drug and dietary supplement landscape. Prominent entities in this sphere are introducing novel products to bolster their market standing. For instance, Dr. Reddy’s Laboratories Ltd., a pharmaceutical powerhouse from India, launched two new OTC products – Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg extended-release tablets, in July 2022. These are over-the-counter oral antihistamine and nasal decongestant medicines that provide temporary respite from nasal and sinus congestion generated by colds or allergies. This introduction has significantly enriched their range of upper respiratory OTC products.
Which Organizations Are Driving Progress In The OTC Drug And Dietary Supplement Industry?
Major companies operating in the OTC drug and dietary supplement market include Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Inc, GSK plc, Gilead Sciences Inc., Reckitt Benckiser Plc., Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Church & Dwight Co Inc, Perrigo Company plc, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Ltd, Nutraceutical International Corporation, Procter & Gamble Health Limited, Reese Pharmaceutical Company, UPM Pharmaceuticals Inc, Gemini Pharmaceuticals Inc., Pharmavite LLC, Now Health Group Inc., Alfresa Pharma Corporation
Which Region Is Expected To Experience The Highest Growth In The OTC Drug And Dietary Supplement Industry?
North America was the largest region in the OTC drug and dietary supplement market in 2024. The regions covered in the OTC drug and dietary supplement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12096&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
